What is the recommended anesthetic management for a healthy liver donor (age 18‑60, body mass index <30 kg/m², normal cardiac and pulmonary function, hemoglobin >12 g/dL, international normalized ratio <1.2, platelets >150 ×10⁹/L) undergoing liver transplantation?

Anesthetic Management of Liver Donor Liver Transplant

For healthy living liver donors undergoing hepatectomy, general anesthesia with careful hemodynamic monitoring, restrictive fluid management targeting low central venous pressure (CVP <5 mmHg), avoidance of blood transfusion, and multimodal analgesia (preferably thoracic epidural) should be employed to minimize donor morbidity and optimize graft function.

Preoperative Considerations

The donor represents a unique challenge: a healthy individual undergoing major hepatic surgery with zero personal medical benefit. Your primary ethical obligation is donor safety—morbidity and mortality must be minimized at all costs 1, 2.

Key Preoperative Elements:

• Verify comprehensive donor evaluation is complete (cardiac, pulmonary, hepatic volumetry, vascular anatomy)
• Confirm adequate remnant liver volume (typically >30-35% for right lobe donation)
• Ensure hemoglobin >12 g/dL, platelets >150×10⁹/L, INR <1.2 as baseline 1
• Establish realistic expectations regarding postoperative course and potential complications

Intraoperative Anesthetic Management

Anesthetic Technique

General anesthesia is the standard approach for living donor hepatectomy 3, 4. The choice of agents should prioritize:

• Induction: Propofol (no significant pharmacokinetic alterations in hepatic surgery) with short-acting opioids (fentanyl or sufentanil preferred over morphine) 5, 3
• Maintenance: Volatile anesthetics (isoflurane, sevoflurane, or desflurane) are preferred due to minimal hepatic metabolism and maintenance of hepatic blood flow 5
• Neuromuscular blockade: Short-to-intermediate acting agents (cisatracurium, rocuronium) 3

Hemodynamic Monitoring

Standard monitoring plus invasive arterial line and central venous catheter are essential 3, 4:

• Continuous arterial blood pressure monitoring
• Central venous pressure (CVP) monitoring—critical for fluid management strategy
• Urinary catheter for hourly output monitoring
• Core temperature monitoring
• Consider transesophageal echocardiography (TEE) for volume assessment in complex cases 5

Important caveat: CVP alone may not accurately reflect volume status; TEE assessment of superior vena cava respiratory variability provides superior guidance 5.

Fluid Management Strategy

The cornerstone of donor hepatectomy anesthesia is restrictive fluid management with low CVP technique 5, 6:

Target CVP <5 mmHg during parenchymal transection phase to minimize hepatic venous congestion and reduce blood loss. This is achieved through:

• Judicious crystalloid administration (balanced electrolyte solutions preferred over 0.9% saline to avoid hyperchloremic acidosis) 5
• Avoid hydroxyethyl starch (HES)—associated with acute kidney injury 5
• Consider albumin for volume replacement (may offer advantages over crystalloids based on trauma/sepsis data) 5
• Maintain mean arterial pressure ≥60-65 mmHg with vasopressors (phenylephrine, norepinephrine) rather than excessive fluid 5

Typical intraoperative fluid volumes: Studies show crystalloid administration averaging 2-4 L for procedures lasting 6-8 hours, with minimal colloid use 6, 3, 4.

Blood Conservation

Blood transfusion should be avoided in healthy donors 6, 3, 4:

• Expected blood loss: 550-1600 mL for right lobe, less for left lateral segment 6, 3
• No homologous blood transfusion should be necessary in properly selected donors
• Autologous blood donation preoperatively may be considered
• Cell salvage should be available and used when appropriate 7, 8
• Consider antifibrinolytic prophylaxis (tranexamic acid) for liver surgery at high risk for bleeding 7

Specific Intraoperative Considerations

Maintain hepatic perfusion and oxygen delivery:

• Hepatic blood flow decreases 35-42% in first 30 minutes of anesthesia 5
• Maintain mean arterial pressure >65 mmHg throughout 5
• Avoid prolonged hypotension which compromises remnant liver perfusion
• Prevent hypothermia—maintain normothermia throughout (use forced-air warming, fluid warmers) 8

Surgical phases requiring specific attention:

• Dissection phase: Low CVP technique, restrictive fluids
• Transection phase: Maintain low CVP, anticipate blood loss
• Post-resection: Liberalize fluids cautiously, ensure adequate perfusion to remnant liver

Postoperative Management

Immediate Recovery

• Early extubation is the goal for uncomplicated cases 3
• 4 of 8 donors in one series were extubated in OR; others within 5-25 hours 3
• Transfer to ICU or high-dependency unit for initial 24-48 hours monitoring 3, 4

Pain Management

Thoracic epidural analgesia is the preferred technique 4:

• Provides superior analgesia for upper abdominal incision
• Facilitates early mobilization and respiratory function
• Place preoperatively or immediately postoperatively
• Continue for 3-5 days postoperatively

Alternative: Patient-controlled analgesia (PCA) with opioids if epidural contraindicated or refused

Important: Return of bowel function averages 3.1 days and is not significantly influenced by analgesic technique 4.

Monitoring and Complications

Expected postoperative course:

• Transient elevation of liver enzymes (ALT, AST) is normal 3
• Hemoglobin typically drops 2-3 g/dL immediately postoperatively, recovers by POD 1 3
• ICU stay: 1-3 days 3
• Hospital discharge: 7-17 days 3, 4

Watch for complications:

• Bleeding (most common serious complication)
• Bile leak
• Hepatic insufficiency (rare with adequate remnant volume)
• Venous thromboembolism
• Respiratory complications (atelectasis, pneumonia)

Critical Pitfalls to Avoid

1. Over-resuscitation with fluids: Leads to hepatic congestion, increased blood loss, and potential graft dysfunction
2. Inadequate monitoring: Invasive monitoring is not optional—it's essential for safe management
3. Ignoring temperature: Hypothermia increases bleeding and impairs coagulation
4. Unnecessary blood transfusion: Healthy donors should not require transfusion with proper technique
5. Inadequate pain control: Compromises recovery and donor satisfaction

Special Considerations

Right lobe vs. left lateral segment donation 6:

• Right lobe hepatectomy carries higher blood loss risk (though still minimal: 118±81 mL vs 68±64 mL)
• Anesthetic management principles remain identical
• No difference in fluid requirements when blood loss is minimal

Laparoscopic/robotic approaches 1:

• Increasingly performed for donor hepatectomy
• Same hemodynamic principles apply
• Consider pneumoperitoneum effects on venous return and hepatic perfusion
• May reduce postoperative pain and hospital stay

The evidence base for living donor anesthesia is primarily observational studies and case series [1-4], with no randomized trials. However, the consistent finding across all studies is that meticulous attention to hemodynamic management, blood conservation, and donor safety results in excellent outcomes with minimal morbidity and zero mortality in properly selected donors.